The European Union will manage to stick to its set goals of the vaccination program this quarter despite delayed shipments of AstraZeneca vaccines because Pfizer is producing faster than planned, EU Industry Commissioner Thierry Breton said on Saturday, reports Jutarnji list.
AstraZeneca announced on Friday that it would try to deliver 30 million doses of the vaccine to the EU by the end of March, less than the agreed and contracted 90 million doses.
Breton told French radio Europe 1 that the delay was unacceptable, but that there were no plans to file a lawsuit against the Anglo-Swedish pharmaceutical company.
“The good news is that despite the delays in AstraZeneca, there will be no delays in our vaccination program in the first quarter,” said Breton.
"Pfizer is producing much, much more than it planned, so it will supply us with larger quantities," he added.
EU leaders have been criticized for the slow vaccination process, compared to countries like the UK or the United States, and for the lengthy approval process and repeated delivery delays.
Breton said AstraZeneca has a problem with vaccine testing, which is a sign of a logistical problem, so he called on the company's supervisory board to do something.
He also criticized his compatriot at the helm of the company, Pascal Soriot, for remaining in Australia despite problems at AstraZeneca.